Depression Evaluations for Medication and Brain Imaging Studies
Join a Research Study: Enrolling nationally from around the country
This study screens for various inpatient and outpatient studies that investigate the brain and experimental medications (such as ketamine) to quickly lift severe and hard-to-treat depressive symptoms.
Participation may include outpatient visits or inpatient stays lasting 4 to 20 weeks at the NIH Clinical Center, Bethesda, MD. Procedures may include: tapering off current psychiatric medications, a medication-free period, oral or intravenous medication versus placebo, and brain scans. You may also qualify for other studies that have different requirements and lengths of stay.
Participants must be ages 18-70 and free of serious medical conditions. These studies may enroll eligible participants from across the USA. Travel arrangements and compensation are provided. There is no cost to participate.
First steps to participate include, calling NIMH, learning study details, asking about your eligibility, and consenting to participate.
- NIMH Protocol Number: 01-M-0254
- ClinicalTrials.gov Study Number: 00024635
Investigator(s): Carlos Zarate Jr, M.D.